Is the Company Considering a Secondary Listing in Abu Dhabi? Insilico Medicine Responds
1 day ago / Read about 0 minute
Author:小编   

Insilico Medicine issued an announcement stating that the company's board of directors has noted recent media reports suggesting the company's intention to pursue a secondary listing in Abu Dhabi. We hereby inform shareholders and investors that the company will from time to time consider and evaluate post-listing capital operations, including the feasibility of a secondary listing in other capital markets. However, at present, the company does not have any specific plans for a secondary listing. In the event of significant developments, the company will make a timely announcement in accordance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.